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Paramyxoviruses enter cells by fusion of their lipid envelope with the target cell plasma membrane. Fusion of the viral membrane with the plasma
membrane allows entry of the viral genome into the cytoplasm. For paramyxoviruses, membrane fusion occurs at neutral pH, but the trigger
mechanism that controls the viral entry machinery such that it occurs at the right time and in the right place remains to be elucidated. Two viral
glycoproteins are key to the infection process—an attachment protein that varies among different paramyxoviruses and the fusion (F) protein, which
is found in all paramyxoviruses. For many of the paramyxoviruses (parainfluenza viruses 1–5, mumps virus, Newcastle disease virus and others), the
attachment protein is the hemagglutinin/neuraminidase (HN) protein. In the last 5 years, atomic structures of paramyxovirus F and HN proteins have
been reported. The knowledge gained from these structures towards understanding the mechanism of viral membrane fusion is described.
D 2005 Elsevier Inc. All rights reserved.Keywords: Viral fusion proteins; Attachment protein HN; Membrane fusion; Paramyxovirus; Fusion activation
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Fig. 1. The paramyxovirus fusion protein and class I fusion protein core trimers.
(A) Cleavage activation of a prototypical paramyxovirus F protein from
parainfluenza virus 5 (PIV5). The position of the signal sequence, the TM
domain, the cleavage site, the hydrophobic fusion peptide and the heptad
repeats A and B are indicated. 252 amino acid residues separate the two heptad
repeats. (B) Similar hairpin structures are formed by fragments of the
membrane-anchored polypeptides of the fusion proteins from different viruses.
(Modified from Baker et al., 1999.)
R.A. Lamb et al. / Virology 344 (2006) 30–37 31infection process—an attachment protein that varies across viral
families and the fusion (F) protein, which is found in all
paramyxoviruses. For many of the paramyxoviruses (NDV,
PIVs 1–5 and others), the attachment protein is the hemagglu-
tinin/neuraminidase (HN) protein, but the morbilliviruses, such
as measles virus, carry a hemagglutinin (H) protein in place of
HN, while the pneumoviruses (RSV) and henipaviruses (Nipah
and Hendra) express a distinct attachment glycoprotein (G).
Class I viral fusion proteins
Many viruses, such as influenza viruses, paramyxoviruses,
human immunodeficiency virus, herpes viruses and dengue
fever virus are enveloped in a lipid membrane and to replicate,
these viruses must enter a cell by fusing their own membrane
coat with that of the cell. Fusion is caused by viral glycoproteins
that are inserted in the viral membrane. The paramyxovirus F
proteins belong to the class I viral fusion protein type, of which
the best characterized member is the influenza virus hemagglu-
tinin (HA), but which also includes the fusion proteins from
retroviruses, coronaviruses, Ebola virus and others (Colman and
Lawrence, 2003; Dutch et al., 2000; Earp et al., 2005; Jardetzky
and Lamb, 2004). Models for Class I viral fusion protein-
mediated membrane merger have been developed primarily
from the structural studies of HA (Skehel and Wiley, 2000). In
general, class I viral fusion proteins follow the following
paradigm. Three identical polypeptide chains assemble into
trimers, which are subsequently proteolytically cleaved into two
fragments at a specific site N-terminal to an internal hydrophobic
domain of approximately 25 amino acids, commonly referred to
as the fusion peptide (Fig. 1A). Sequences adjacent to the fusion
peptide and the transmembrane (TM) anchor domain typically
reveal a 4–3 (heptad) pattern of hydrophobic repeats and are
designated HRA and HRB, respectively.
Core trimers of class I viral fusion proteins
Biophysical data indicated that HRA and HRB form a
complex and crystallographic studies have shown that HRA and
HRB form a helical hairpin or 6-helix bundle structure (core
trimer) that is related to that observed for the low-pH-induced
proteolytic fragment of HA. For example, the core trimers of
PIV5 and hRSV F (Baker et al., 1999; Zhao et al., 2000), HIV
gp41 (Caffrey et al., 1998; Chan et al., 1997; Tan et al., 1997;
Weissenhorn et al., 1997), Moloney murine leukemia virus
envelope protein (Fass et al., 1996), Ebola GP2 (Malashkevich
et al., 1999; Weissenhorn et al., 1998) and HTLV-1 (Kobe et al.,
1999) fusion proteins all share this similarity in structure (Fig.
1B). While the structural details vary, all reveal a trimeric,
coiled-coil beginning near the C-terminal end of the hydropho-
bic fusion peptide. The C-terminal segment abutting the TM
domain is also often helical and packs in an antiparallel direction
along the outside of the N-terminal coiled-coil, placing the
fusion peptides and TM anchors at the same end of a rod-like
structure. These 6-helix bundles (6HB) typically represent a
relatively small fraction of the intact fusion protein, yet their
structures are generally highly thermostable, with meltingtemperatures near 100 -C. Intermediates along the pathway of
membrane fusion can be trapped by the addition of peptides
derived from either the N-terminal (HRA) or C-terminal (HRB)
heptad repeat regions for many class I fusion proteins (Earp et
al., 2005; Eckert and Kim, 2001; Fass, 2003), indicating that the
intact protein undergoes conformational changes that expose
both HR regions, prior to refolding to the final 6HB. The
intermediates are thought to represent partially refolded forms of
the fusion protein, with a hydrophobic fusion peptide anchored
in the target cell membrane and the TM domains anchored to the
viral membrane. The formation of the 6HB is tightly linked to the
merger of lipid bilayers, and is thought likely to couple the free
energy released on protein refolding to membrane fusion
(Melikyan et al., 2000; Russell et al., 2001).
Fusion triggering
The triggering event that initiates membrane fusion by
different viruses varies substantially for different viral fusion
proteins. For influenza virus, membrane fusion occurs upon
exposure to the low pH environment of the endosome (Bullough
et al., 1994; reviewed in Hernandez et al., 1996), while HIVentry
into cells is triggered by binding to the cell-surface proteins CD4
in conjunction with one of the chemokine receptor family
members (Damico et al., 1998; Furuta et al., 1998; Hernandez et
Fig. 2. The N-1 and C-1 peptides inhibit fusion in a temporal manner. CV-1
cells coexpressing PIV5 HN and F protein (FR3) mutated at the cleavage site to
prevent intracellular cleavage, were incubated with TPCK-trypsin for 1 h to
cleave the F0 precursor to the F1 and F2 subunits. RBCs colabeled with
octadecyl rhodamine (R18) (red) and carboxyfluorescein (CF) (green) were
bound to the CV-1 cells at 4 -C for 1 h. The samples were incubated at 37 -C
for 10 min, reincubated at 4 -C and analyzed for dye transfer by confoca
microscopy. Either the N-1 or C-1 peptides were incubated with the samples a
the following stages of the assay: (A) no peptide at any stage; (B) peptide
before and after cleavage; (C) peptide during RBC binding at 4 -C and (D
peptide during the 37 -C incubation. The samples were washed three times with
PBS between each stage. The peptide concentrations were 40 AM. (From
Russell et al., 2001 with permission.)
R.A. Lamb et al. / Virology 344 (2006) 30–3732al., 1997; Moore et al., 1990). For the paramyxoviruses,
membrane fusion occurs at neutral pH, but the trigger
mechanism for viral entry remains to be elucidated, although
most likely it involves specific interactions with the attachment
protein (HN, H or G) (reviewed in Lamb, 1993; Lamb and
Kolakofsky, 2001).
Protein refolding and membrane fusion
The general mechanism for class I viral fusion proteins posits
the folding of the uncleaved protein to a metastable state, which
can be activated to undergo large conformational changes to a
more stable fusogenic or post-fusion state. For the influenza HA
protein, crystal structures of three forms of the protein have been
determined which support this model and provide the structural
basis for the general class I mechanism (Bullough et al., 1994;
Chen et al., 1998, 1999; Wilson et al., 1981). Influenza HA
structures have been determined for the uncleaved (HA0) form
(Chen et al., 1998), the cleaved/activated form (HA1/HA2)
(Wilson et al., 1981) and the post-fusion form activated by low
pH or revealed by the recombinant expression of the C-terminal
HA2 fragment (Bullough et al., 1994; Chen et al., 1999). Minor
conformational changes are observed between the HA0 and
HA1/HA2 structures, which reveal the fusion peptide, initially at
the protein surface in HA0, tucked into the interior of the HA2
coiled-coil after proteolysis. The low-pH-induced, post-fusion
form shows a dramatic refolding of the HA2 fragment, bringing
the fusion peptide and TM anchors into close proximity. For HA,
it is thought that proteolytic cleavage primes the protein for
membrane fusion (Skehel and Wiley, 2000), potentially influ-
encing the stability of the pre-fusion state. Thus, the attainment
of the pre-fusion conformation, its regulation and relative free
energy as compared to the post-fusion form are all key to the
process by which class I viral fusion proteins function.
Paramyxovirus fusion: capture of intermediates of fusion
To understand the conformations of the F protein from its
pre-fusion state through to the post-fusion state, it is necessary
to understand the mechanism of activation of F from the
metastable state. It was shown that the isolated peptides, called
N-1 and C-1, that correspond to the F protein heptad repeats
(HRA and HRB, respectively), inhibit fusion (Baker et al.,
1999; Joshi et al., 1998). These peptides were then used as
tools to dissect the steps in F protein activation from a
metastable state (Russell et al., 2001). Both thermal energy and
receptor binding by the homotypic HN were found to
contribute to F activation (Fig. 2). The N-1 peptide inhibited
fusion at an earlier stage (cells incubated at 4 -C) than the C-1
peptide (inhibits only after warming cells to 37 -C), strongly
suggesting that the site to which N-1 binds in the F protein is
available before the site to which the C-1 peptide binds and that
generation of the site to which C-1 binds requires thermal
energy (Fig. 2). However, when HA was used as the binding
protein in place of HN, even though fusion takes place (albeit
less efficiently than when HN is coexpressed), N-1 does not
inhibit fusion at 4 -C unlike when HN is used as the bindingl
t
)protein but N-1 inhibition does occur on warming the cells to
37 -C. These data strongly suggest that the role of HN is more
complex than the mere binding of receptor and indicates that
even at 4 -C, HN binding to receptor causes a conformational
change in the F protein. In the absence of HN, the
conformational change in F can be induced by heating. By
using a tagged C-1 peptide, it was shown that the peptide
bound to F, and inhibited an intermediate of F that existed until
a point preceding membrane merger (Russell et al., 2001).
Membrane-incorporated lipids can promote or inhibit fusion in
a manner that correlates with their dynamic molecular shapes
by either favoring or preventing formation of membrane stalk
intermediates of fusion (Chernomordik et al., 1997). F protein-
mediated fusion was reversibly arrested by addition of the
membrane-binding lipid stearoyl-lysophosphatidylcholine
(LPC), which has been shown to inhibit fusion at the point
of membrane merger (Chernomordik et al., 1998). By using a
temporal order of addition experiment, evidence was obtained
indicating that the proteins actively drive membrane fusion by
coupling irreversible protein refolding (forming the 6HB) to
membrane juxtaposition (Russell et al., 2001). Related data
from studies on HIV gp120/gp41 (Melikyan et al., 2000) led to
very similar conclusions.
A dual-functional F protein regulatory switch segment:
activation and membrane fusion
An unanticipated glimpse of F protein activation came from
an examination of the PIV5 6HB (Baker et al., 1999). There is
Fig. 3. Mutants in the PIV5 C-1 extended chain region that pack into the core trimer have little effect on 6-helix bundle stability but have dramatic effects on fusion
activation. (A) Schematic diagram of the paramyxovirus fusion (F) protein. The positions of the fusion peptide (FP), HRA (residues 129–184), h-barrel domain (h-
barrel), immunoglobin-like domain (Ig-like), HRB (residues 449–477) and TM domain are shown. The locations of the N-1 and C-1 peptides from PIV5 F are
indicated. The asterisks denote PIV5 residues P22 and P443 and the NDV mutant L289Awhich have been implicated previously in HN-independent fusion. (Ito et
al., 2000; Paterson et al., 2000; Sergel et al., 2000) (B) Sequence alignment of the N-1 and C-1 peptides derived from PIV5 F with the corresponding residues of F
proteins from other paramyxovirus genera. HRSV, human respiratory syncytial virus. The asterisks denote the PIV5 N-1 cavity residues, the C-1 cavity-binding
residues L447 and I449 and residue 443 that has a hyperactive fusion phenotype when mutated to a proline residue. (C) High-resolution structure of the PIV5 6-helix
bundle (6HB) (Baker et al., 1999). The core N-1 trimer is depicted in a surface representation colored by surface curvature and the antiparallel C-1 monomers are
depicted by coil representations (magenta). (D) The packing of L447 and I449 into the hydrophobic N-1 cavity. Three N-1 (green) and one C-1 (magenta) chains are
depicted by coil representations. (From Russell et al., 2003 with permission.)
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HRB side chains L447 and I449 pack tightly (Fig. 3). Mutation
of these HRB residues to aromatic residues had little effect on
bundle formation as trimers (measured by analytical ultracen-
trifugation) or stability (as measured by circular dichroism and
thermal melting). Surprisingly, when these mutations were
introduced into an intact F protein and fusion assayed in cells, a
profound effect on F protein activation was found: furthermore,
these mutants were hyperactive in fusion. The data indicate that
the residues adjacent to HRB regulate the stabilization and
activation of pre-fusion metastable F. The data are consistent
with this linear segment having dual interaction sites in F, oneFig. 4. Model showing the steps for paramyxovirus F protein fusion conformation ch
al., 2003 with permission.)in metastable F and one in the 6HB, thereby providing key
regulation of the switch between the metastable and fusion-
active forms of F (Russell et al., 2003). These data play a very
important role in the interpretation of the atomic structure of
the intact uncleaved paramyxovirus F protein (see below).
A model for paramyxovirus-mediated fusion
The cascade of paramyxovirus F protein conformational
changes that take place while mediating membrane fusion is
illustrated in Fig. 4: native structure (which is in a metastable
conformation), a temperature-arrested intermediate (whichanges causing virus–cell fusion. See text for a full description. (From Russell et
Fig. 5. Structure of the hPIV3 solF0 protein. (A) Schematic of the domain
structure of the hPIV3 solF0 protein. Domain regions are indicated with hPIV3
sequence numbers shown below and with colors corresponding to those used in
Figs. 1B, D and E. (B) Ribbon diagram of the hPIV3 solF0 trimer. The three
chains are colored similarly from blue (N-terminus) to red (C-terminus)
Residues 95–135 are disordered in all chains. Residue 94 is labeled in one
chain and residues 136–140 at the base of the stalk are ordered in one chain
due to crystal packing interactions. (C) Surface representation of the solF0
trimer. Each chain is a different color and Domains I– III and HRB for one
chain (yellow) are indicated by the DI, DII, DIII and HRB labels. One radia
channel is readily apparent below Domain I and II of the yellow chain and
above Domain III of the red chain. (D) Ribbon diagram of the solF0 protein
monomer colored by domain. The direct distance within one monomer between
residue 94 at the end of HRC and residue 142 at the base of the stalk region is
122 A˚. (E) Ribbon diagram of the monomer rotated by 90-, indicating the width
and height of the solF0 monomer. An arrow at the C-terminus of the HRB
segment points towards the likely position of the transmembrane ancho
domain that would be present in the full-length protein. (From Yin et al., 2005
with permission.)
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temperatures and is susceptible to N-1 binding), a pre-hairpin
intermediate (which adheres to target cells independent of HN
and is susceptible to C-1 binding) and the post-fusion
(sometimes called the Fusogenic) form of F (its formation
couples 6HB formation to membrane merger). The experimen-
tal data discussed above are consistent with residues 447 and
449 having distinct interaction sites on the F protein, one in the
native structure and the other in the cavity formed by HRA
trimers in the 6HB of the post-fusion form. The strong
correlation between 6HB stability and C-peptide inhibitory
potency (Russell et al., 2003) and the coincidence of C-1
inhibition and F protein binding in a previous study (Russell et
al., 2001) show that C-1 inhibits membrane fusion by binding
to transiently exposed HRA triple-stranded coiled-coils in the
pre-hairpin intermediate. Biophysical studies on the N-1/C-
peptide mutants show that the aliphatic (al) and aromatic (ar)
mutations at L447 and I449 decrease the amount of energy
released by mutant 6HB formation; whereas, functional studies
on the F mutants are consistent with the aromatic (ar) mutations
decreasing and the aliphatic (al) mutations increasing the
activation energy barrier of the native state. The hyperactive
fusion phenotype of the aromatic mutants is consistent with the
facile activation (and subsequent inactivation in the absence of
a fusion target) of these F mutants overcompensating for the
decrease in energy released by mutant 6HB formation.
Atomic structure of the uncleaved ectodomain of the hPIV3
F protein
A partially proteolyzed structure of a soluble form of the
Newcastle disease virus (NDV) F protein was obtained (Chen et
al., 2001), revealing the fold of much of the extracellular region
of F, forming a trimer, with distinct head, neck and stalk regions,
but raising many questions regarding the conformational state
of the protein and its relationship to postulated pre-fusion and
post-fusion forms. Working on the assumption that all
paramyxovirus F proteins mediate fusion by a common
mechanism and that the different F proteins will have a closely
related structure, given the conservation of cysteine and proline
residues among all paramyxovirus F protein sequences, we
decided to take a Fgenomics_ approach and we expressed,
purified and attempted to crystallize the uncleaved F protein of
nine different paramyxoviruses. To date, the best data came
from hPIV3 F. The hPIV3 F protein was expressed in insect
cells using the baculovirus system after appending a secretion
signal sequence to the mature N-terminus and truncating the
protein just prior to the membrane anchor domain (solF0). We
crystallized hPIV3 solF0 and single crystals were analyzed by
SDS-PAGE to test for potential degradation, as was observed in
the crystallization of the NDV F protein (Chen et al., 2001). For
hPIV3 solF0, only the intact protein was observed (Yin et al.,
2005). The atomic structure of hPIV3 solF0 was solved to 3.05
A˚ by molecular replacement using as a model a fragment of the
NDV F structure (Yin et al., 2005). The hPIV3 F forms a trimer,
with distinct head, neck and stalk regions (Fig. 5). The only part
of the structure lacking electron density is the fusion peptide and.
l
rcleavage site, but these residues would be draped flexibly on the
exterior of the stalk region. Given that the uncleaved F protein
was crystallized, it was unexpected that the structure contains a
6-helix bundle (Fig. 5) that is thought to represent the post-
fusion conformation of the protein. Many lines of evidence
suggest that the observed conformation primarily represents the
R.A. Lamb et al. / Virology 344 (2006) 30–37 35post-fusion form, although the polypeptide chains are intact in
the crystal and the fusion peptide is not located at the
appropriate end of the 6HB. The 6HB appears to be well
formed and undistorted, similar to the previously determined
PIV5 and hRSV F 6HB structures (Baker et al., 1999; Zhao et
al., 2000). The hPIV3 structure appears to be inconsistent with
peptide inhibition data that show, at least for PIV5 F, that the
HRA and HRB peptides are exposed at distinct steps of the
membrane fusion reaction (Russell et al., 2001 and see Fig. 2).
In the current structure, the release of HRB from 6HB would
simultaneously expose HRA sites to inhibition, which conflicts
with the peptide inhibition data. Instead, the hPIV3 structure
would predict that both HRA and HRB peptides would acquire
the ability to inhibit membrane fusion simultaneously, requiring
the observed 6HB to dissociate in order to be consistent with the
previous mechanistic studies. From the current structure, it is
also not clear how membrane fusion could be achieved.
Cleavage of the hPIV3 solF0 protein would appear to simply
allow repositioning of the fusion peptide to the N-terminus of
the HRA coiled-coil, and concomitant insertion into the
anchoring membrane for the TM domain. Finally, the current
structure cannot explain the behavior of F protein mutants that
destabilize the pre-fusion conformation of F and significantly
enhance its membrane fusion activity (Colman and Lawrence,
2003; Paterson et al., 2000; Russell et al., 2003) (see Figs. 3–5).
Mutation of two hydrophobic residues of HRB in PIV5 (447
and 449 in PIV5 corresponding to 454 and 456 in hPIV3) to
larger aromatic residues, leads to a hyper-fusion phenotype of
the PIV5 F protein, which is most easily interpreted as leading
to a destabilization of the pre-fusion conformation (Russell et
al., 2003). The mutation of conserved glycine residues in the
fusion peptide leads to similar behavior (Russell et al., 2004).Fig. 6. Atomic structure of the PIV5 hemagglutinin-neuraminidase at 2.6 A˚ resolu
correspond to protease cleavage sites in the pBacgus-3 vector. (B) SDS-PAGE anal
conditions. (C and D) Schematic cartoon showing top and side view of PIV5 HN. H
shown in blue and the C-terminus in red. The missing loop from residues 186 to 1
marked by space filling representations of the ligand, sialyllactose. The four subu
arrangement; (Right) side view of PIV5 HN tetramer arrangement, with a 60- pack
soaked crystal at 2.5 A˚ resolution. (G) A model for HN tetramer rearrangement upon
terminal stalk region and can interact with F protein. Sialic acid receptors are display
active; NA) domains could perturb the NA tetramer arrangement, consistent with
tetramer could affect interactions and trigger membrane fusion. (From Yuan et al.,The structure of hPIV3 solF0 (Fig. 5) also raises questions
regarding the formation and stability of the pre-fusion
conformation of the paramyxovirus F protein. If the soluble,
secreted hPIV3 and NDV F proteins, and by inference other
paramyxovirus family members as well, primarily adopt a post-
fusion conformation, there are at least two possible explana-
tions for this behavior. First, the TM anchor (and potentially the
cytoplasmic tail; Waning et al., 2004) could be an important
determinant of the stability of the pre-fusion conformation,
providing a significant fraction of the energy barrier that traps
the protein in a metastable state. In this case, the secreted
protein may fold to the pre-fusion form transiently, but then
refold to the post-fusion form. A second possible explanation
for the structural results is that the TM domain is important for
the protein to attain the pre-fusion metastable state and that in
the absence of this region, the soluble F protein folds directly to
the final, most stable post-fusion conformation. In either case,
it appears that the amino acids comprising the intact F protein
ectodomain are not sufficient for the protein to fold to and
maintain a metastable conformation.
Atomic structure of HN and the role(s) of HN in fusion
activation
A large body of data supports the view that HN promotes
fusion by the paramyxovirus virus F protein (reviewed in Lamb
and Kolakofsky, 2001). It is now generally thought that F with
the homotypic HN (H or G) protein has to be expressed in the
same cell and biochemical data indicate that F and HN
coassociate (reviewed in Morrison, 2003). Thus, knowledge
of the atomic structure of HN may help to understand HN
activation of F for membrane fusion. To date, the atomiction. (A) Construct for expression of HNecto in insect cells. Downward arrows
ysis of HNecto and dissolved HNecto crystals under reducing and non-reducing
elices are shown in cylinders and h-strands in arrowed belts. The N-terminus is
90 is indicated as dashed blue lines. (E) PIV5 HN tetramers. Active sites are
nits are shown in different colors. (Left) Top view of the PIV5 HN tetramer
ing angle between dimers. (F) Electron density observed for a2,3-sialyllactose
cell-surface receptor binding. The HN tetramer is primarily stabilized by the N-
ed at the cell surface, where binding of the individual HN head (neuraminidase
the weak interactions between NA domains. Changes in the HN NA domain
2005 with permission.)
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Zaitsev et al., 2004), hPIV3 (Lawrence et al., 2004) and PIV5
(Yuan et al., 2005) has been determined.
For PIV5 HN, the entire HN ectodomain (HNecto), residues
37–565, was expressed in insect cells from recombinant
baculoviruses (Fig. 6A). Secreted HN protein was purified to
homogeneity by using Co2+ affinity chromatography and gel
filtration chromatography. HNecto elutes from a gel filtration
columnwith aMr¨265 kDa, which is very close to the predicted
mass of the tetramer (250–260 kDa). On non-reducing SDS-
PAGE, HNecto migrates at the size expected for a disulfide-
linked dimer (Fig. 6B). These observations indicate that HNecto
forms disulfide-linked dimers through C111 and the dimers
associate into tetramers in solution, consistent with previous
studies of the HN oligomeric arrangement (Ng et al., 1989,
1990). The formation of a stable HN tetramer in solution requires
the N-terminal stalk region of the protein. PIV5 HNecto was
crystallized and the structure was determined by molecular
replacement using NDV HN as a model (Figs. 6C and D). The
structures of HNecto with sialic acid, the inhibitor DANA and
with sialyllactose were also determined (Yuan et al., 2005).
The salient results from the structural studies on PIV5 HN
(Yuan et al., 2005) are as follows. (1) The HN receptor
sialyllactose was found in an intact form at pH 8.0 and the
sialic acid moiety exists in a distorted conformation induced by
interactions with HN. (2) The HN ectodomain exists as a
tetramer in solution and the presence of the stalk region is critical
for the formation of the stable tetramer. However, in the HNecto
crystal structure, even though the protein is intact (Fig. 6), the
stalk region was not visible in the electron density suggesting the
linker region between the stalk and NA domains is flexible. (3)
The PIV5 HN contains only one sialic binding site unlike for
NDV that contains two sialic binding sites, the catalytic site and
a second site formed by the juxtaposition of two monomers
(Zaitsev et al., 2004). However, for PIV5, HN not only was a
second sialic acid molecule not observed but the PIV5 HN
molecule could also not form the second sialic acid binding site
between two monomers due to changes in sequence and
conformation. (4) The PIV5 HN sialic acid-binding active site,
like that of hPIV3 HN (Lawrence et al., 2004), does not undergo
conformational change on binding ligand, unlike those proposed
for NDV HN where ligand binding to the catalytic site is
proposed to influence the oligomeric arrangement of NDV HN
and create the second sialic acid binding site (Crennell et al.,
2000; Zaitsev et al., 2004). Based on the second sialic acid
binding site in NDV HN, Zaitsev et al. (2004) proposed a model
for HN activating F for fusion.
For PIV5, an alternative model for HN involvement in
membrane fusion was proposed that is consistent with the
available data and that involves ligand-dependent changes in the
HN oligomer that are driven by surface:surface interactions (Fig.
6) (Yuan et al., 2005). In this model, the HN dimer/tetramer
forms in the absence of ligands and can interact with the F
protein, potentially through lateral interactions on two sides of
the tetramer. Engagement of cell surface receptors could trigger
the partial disassembly of the HN tetramer, assuming that the
energy of binding of the individual HN sites to distinct sialicreceptors is sufficient to perturb the weak NA domain interac-
tions. Opening of the tetrameric head, driven by the energy of
receptor engagement, could lead to changes in both the HN stalk
region (the HN stalk domain is thought to interact with F)
(reviewed in Colman and Lawrence, 2003) and the interaction
with F, thus activating F for membrane fusion.
Conclusions
In the last 5 years, atomic structures of F and HN proteins of
paramyxoviruses have brought new knowledge towards under-
standing the mechanism of viral membrane fusion. However, a
great deal more information is needed. The key studies needed
for understanding paramyxovirus-mediated membrane fusion
are: (1) obtaining the structure of the uncleaved metastable form
of F; (2) understanding the conformation of the metastable
cleaved F protein; (3) learning how HN protein activates fusion
and (4) studying the interactions between F and HN. These
mechanistic studies require both structural information and
biochemical experiments if a complete understanding of fusion
is to be obtained.
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